Research analysts at StockNews.com started coverage on shares of RiceBran Technologies (NASDAQ:RIBT – Get Rating) in a research report issued to clients and investors on Sunday. The brokerage set a "sell" rating on the stock.

RiceBran Technologies Stock Performance

Shares of RiceBran Technologies stock opened at $0.31 on Friday. The firm has a market cap of $16.16 million, a P/E ratio of -1.40 and a beta of 0.12. The company has a current ratio of 1.29, a quick ratio of 1.06 and a debt-to-equity ratio of 0.07. RiceBran Technologies has a 12 month low of $0.27 and a 12 month high of $0.98. The stock's fifty day moving average price is $0.53 and its 200-day moving average price is $0.48.

Insider Activity at RiceBran Technologies

In related news, major shareholder Grain Co Continental sold 150,000 shares of the firm's stock in a transaction dated Monday, May 16th. The stock was sold at an average price of $0.60, for a total transaction of $90,000.00. Following the sale, the insider now owns 5,340,161 shares of the company's stock, valued at $3,204,096.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders have sold a total of 2,730,000 shares of company stock valued at $1,542,000 over the last quarter. 3.81% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On RiceBran Technologies

About RiceBran Technologies

(Get Rating)

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends.

Read More

• Get a free copy of the StockNews.com research report on RiceBran Technologies (RIBT)
• MarketBeat: Week in Review 8/1 – 8/5
• How to Use High Beta Stocks to Maximize Your Investing Profits
• Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
• Beyond Meat Is Not Beyond Hope, And It's Cheap
• Why Apple Could Be At All-Time Highs By Year End

Receive News & Ratings for RiceBran Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RiceBran Technologies and related companies with MarketBeat.com's FREE daily email newsletter.